[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100433517":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":29,"locations":36,"responsibleParty":56,"collaborators":10,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":67,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":73,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Sir Mortimer B. Davis - Jewish General Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group A: Patients",null,"Recruitment for this group will take place at either the radiation-oncology department or at the colorectal surgery department, at the time of consultation or at the time of diagnosis, before the treatment setting. Once clinical staging is available, the surgeon and\u002For radiation-oncologist and\u002For research assistant should identify eligible patients. Patients that comply with selection criteria (inclusion\u002Fexclusion) will be approached by a research team member. For those patients interested in participating, the e-link to the consent form for this group will be sent by email. Once a patient decides to sign the consent form, the link for the questionnaire Q1 will be sent by email.",[13],"Behavioral: The only intervention will be the information brochure that will be given after the first questionnaire.",{"label":15,"type":10,"description":16,"interventionNames":17},"Group B: Physicians","Health professionals will be approached by the research team. The study aim will be explained, and participants that agree to participate will be provided an e-link to consent for this group. Once the health care participant decides to sign the consent form, the link for the questionnaire Q1 will be sent by email.",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"BEHAVIORAL","The only intervention will be the information brochure that will be given after the first questionnaire.","The information brochure will be given to both groups at the same time at 2-3 weeks after the first consultation (patients group) or after answering the first questionnaire (physicians group).",[9,15],[25],{"name":26,"affiliation":27,"role":28},"Té Vuong","Lady Davis Institute - JGH","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":34,"email":35},"Emma Starr, BHSc","CONTACT","514-340-8222","28443","emma.starr.ccomtl@ssss.gouv.qc.ca",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Jewish General Hospital","RECRUITING","Montreal","Quebec","H3T 1E2","Canada","CA",{"type":46,"coordinates":47},"Point",[48,49],-73.58781,45.50884,{"lat":49,"lon":48},[52],{"name":53,"role":32,"phone":33,"phoneExt":54,"email":55},"Té Vuong, MD","22073","te.vuong.med@ssss.gouv.qc.ca",{"type":28,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Dr. Te Vuong","Radiation-oncologist","100433517","tradeoffs-in-patient-decision-making-about-rectal-cancer-treatment-benefits-compared-to-quality-of-life-100433517",false,"NCT04925154","Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.","PATHOS Tradeoffs in Patient Decision Making About Rectal Cancer Treatment: Benefits Compared to Quality Of Life.","Pathos","Inclusion Criteria:\n\nGroup A\n\n* New rectal cancer patient\n* Operable patients\n* Capable adults older than 18 years of age\n* Capacity to sign a consent form\n* Capacity to answer questionnaires on an online platform Group B\n* Treating physician specialists\n* Capacity to sign a consent form\n* Capacity to answer questionnaires on an online platform\n\nExclusion Criteria:\n\nGroup A:\n\n* Patient unable to sign a consent form\n* Patients with metastasis\n* Recurrent tumours\n* Inability to answer questionnaires on an online platform\n* Inability to communicate in french or english\n\nGroup B:\n\n* Participant unable to sign a consent form\n* Inability to answer questionnaires on an online platform",true,"ALL","18 Years",{"count":71,"type":72},192,"ESTIMATED","3 Weeks","OBSERVATIONAL","This study is aiming to look into patients' treatment preferences and their socio economic background as well as the exploration of thought processes leading to these preferences. It will integrate, in two exploratory questionnaires, the three most common treatment schema (standard of care, non-operative management, surgery alone) all of which have been demonstrated efficacious.",[77],"Patient Preference",[79,80],"Colorectal cancer","Treatment preferences","2026-05-11",{"date":83,"type":84},"2026-05-14","ACTUAL",{"date":86,"type":84},"2021-12-13",{"date":88,"type":72},"2028-01-01",{"name":5,"class":6},1]